Life Sciences Start Up Business Funding
NCBiotech understands the importance of emerging entrepreneurial companies to the state’s life sciences landscape.
Through the Emerging Company Development program, NCBiotech invests in promising, emerging life sciences companies across the state.
These investments help recipients conduct meaningful research and achieve commercial milestones. This, in turn, enables them to attract additional funding to fuel their growth. Historically, each dollar of NCBiotech investment has been followed by an average of $140 in follow-on funding. This funding includes government grants, angel and venture capital investments, IPOs and strategic partnerships.
Start Up Life Science Business Investments
Supports business inception and research critical to developing products, processes, or tools with clear commercial potential.
Award range: $150,000 to $350,000
Supplements investments with angel or venture capital investments to fund life sciences companies that have established technical proof-of-concept and require further support to accelerate growth.
Award range: $350,000 to $650,000
For additional funding resources, check out a list of North Carolina's angel and venture capital funding groups. You can also contact NCBiotech's Life Science Intelligence team for tailored assistance.